Penumbra, Inc. $PEN Position Lifted by Machina Capital S.A.S.

Machina Capital S.A.S. raised its position in Penumbra, Inc. (NYSE:PEN) by 17.7% in the 3rd quarter, Holdings Channel reports. The firm owned 12,263 shares of the company’s stock after buying an additional 1,840 shares during the period. Machina Capital S.A.S.’s holdings in Penumbra were worth $3,904,000 at the end of the most recent quarter.

Several other hedge funds also recently bought and sold shares of PEN. Mitsubishi UFJ Asset Management Co. Ltd. acquired a new stake in Penumbra in the second quarter worth $25,000. Keating Financial Advisory Services Inc. bought a new position in shares of Penumbra during the second quarter worth $31,000. MassMutual Private Wealth & Trust FSB grew its holdings in shares of Penumbra by 48.7% in the 3rd quarter. MassMutual Private Wealth & Trust FSB now owns 116 shares of the company’s stock valued at $37,000 after buying an additional 38 shares during the period. CoreCap Advisors LLC grew its holdings in shares of Penumbra by 1,066.7% in the 3rd quarter. CoreCap Advisors LLC now owns 140 shares of the company’s stock valued at $45,000 after buying an additional 128 shares during the period. Finally, Northwestern Mutual Wealth Management Co. acquired a new position in shares of Penumbra in the 2nd quarter valued at $51,000. 88.88% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

PEN has been the subject of a number of recent analyst reports. Weiss Ratings upgraded shares of Penumbra from a “hold (c)” rating to a “hold (c+)” rating in a research report on Friday, October 30th. Zacks Research upgraded Penumbra from a “strong sell” rating to a “hold” rating in a report on Monday, August 24th. Three equities research analysts have rated the stock with a Buy rating and fourteen have issued a Hold rating to the company’s stock. According to data from MarketBeat.com, Penumbra has an average rating of “Hold” and a consensus target price of $367.07.

Penumbra Price Performance

Shares of PEN opened at $321.78 on Thursday. The company has a debt-to-equity ratio of 0.01, a quick ratio of 3.92 and a current ratio of 5.89. The stock has a 50 day simple moving average of $320.23 and a 200 day simple moving average of $326.47. Penumbra, Inc. has a 52-week low of $274.20 and a 52-week high of $362.41. The firm has a market capitalization of $12.68 billion, a PE ratio of 81.38 and a beta of 0.71.

Penumbra (NYSE:PEN) last posted its earnings results on Thursday, October 29th. The company reported $1.07 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $1.20 by ($0.13). The business had revenue of $410.15 million for the quarter, compared to the consensus estimate of $401.41 million. Penumbra had a return on equity of 10.39% and a net margin of 10.06%. Penumbra’s revenue for the quarter was up 15.6% compared to the same quarter last year. During the same period in the previous year, the company posted $0.97 earnings per share. Sell-side analysts predict that Penumbra, Inc. will post 4.96 EPS for the current fiscal year.

About Penumbra

Penumbra, Inc. is a medical technology company that develops and markets devices for treating vascular conditions. Its products are used in neurovascular procedures, including the treatment of ischemic stroke and aneurysms, and in peripheral vascular procedures involving conditions such as pulmonary embolism and deep vein thrombosis. The company’s offerings include aspiration and mechanical thrombectomy systems, embolization coils, and related catheter-based devices. Penumbra was founded in 2004 and is headquartered in Alameda, California.